William Pao: Celebrating a Landmark Breakthrough in Hemophilia Care
William Pao, Adjunct Professor of Pharmacology and Medicine at Joan and Sanford I. Weill Medical College of Cornell University, Chief Executive Officer at Revelio Therapeutics, shared a post on LinkedIn about a recent article by him, published in PNAS, adding:
“Please join me in wishing congratulations to Kunihiro Hattori, Takehisa Kitazawa and Tomoyuki Igawa from Chugai Pharmaceutical Co., Ltd.!
They have just been awarded by The Albert and Mary Lasker Foundation the 2026 Lasker-Debakey Clinical Medical Research Award for invention of a bispecific antibody that joins blood clotting Factors IXa (FIXa) and X (FX), restoring deficient Factor VIII (FVIII) activity in patients with hemophilia A and preventing severe bleeding in this hereditary disorder.
Over the span of 10 years, starting in 2000, Hattori – a molecular and hematology biologist, Kitazawa – a hematology biologist and translational researcher, and Igawa – a biochemist and protein engineer, conceived, designed and created emicizumab, a novel FVIII-mimetic.
Their collective research efforts demonstrate how imagination, determination and multidisciplinary scientific research come together to improve patients’ lives.
Their journey highlights what it takes to make true first-in-class breakthrough medicines for patients.”
Stay updated with Hemostasis Today.
-
Sep 10, 2026, 11:25Andreas Glenthøj: New Sickle Cell Trait Data in UpToDate
-
Sep 10, 2026, 10:53A New Era of Hemophilia Screening and Diagnosis in Women and Girls – ISTH
-
Sep 10, 2026, 10:03Investing in Youth, Transforming Hemophilia Care – WFH
-
Sep 10, 2026, 09:51Ronke Oke BEM: 20 Years of Newborn Sickle Cell Screening in England
-
Sep 10, 2026, 09:41Seunghwan Song: Hemlibra and the Science That Changed Hemophilia A Care
-
Sep 10, 2026, 09:20Mark Dawson: A Radical Rethink of Hemophilia Treatment
-
Sep 10, 2026, 07:26Carly Newton: Every Donation Helps Save Lives
-
Sep 10, 2026, 07:152023 ACR/EULAR APS Classification Criteria – APS Foundation of America
-
Sep 10, 2026, 07:03When Platelet Function Matters More Than Platelet Count – Glanzmann’s Research Foundation